CLOVER HEALTH INVESTMENTS, CORP. /DE
CLOVReported to SECin USCIK 0001801170Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 20. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Reynoso Jamie L.CEO, Medicare Advantage | Open-market sell | $8,7601,921 shares | Sep 18, 2026 | Reynoso Jamie L.CEO, Medicare Advantage | $8,760 | Open-market sell | 1,921 | Sep 18, 2026 |
| OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER | Open-market sell | $14,7093,170 shares | Sep 17, 2026 | OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER | $14,709 | Open-market sell | 3,170 | Sep 17, 2026 |
| Wai ConradCEO, Counterpart Health | Open-market sell | $1,416,000300,000 shares | Sep 16, 2026 | Wai ConradCEO, Counterpart Health | $1,416,000 | Open-market sell | 300,000 | Sep 16, 2026 |
| Soares KarenChief Legal Officer | Open-market sell | $32,7246,846 shares | Sep 15, 2026 | Soares KarenChief Legal Officer | $32,724 | Open-market sell | 6,846 | Sep 15, 2026 |
| Reynoso Jamie L.CEO, Medicare Advantage | Open-market sell | $44,3259,273 shares | Sep 15, 2026 | Reynoso Jamie L.CEO, Medicare Advantage | $44,325 | Open-market sell | 9,273 | Sep 15, 2026 |